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Abstract 
Background: Associations between the γ-aminobutyric acid type-A receptors (GABAA) and 
alcohol dependence risk have been reported, although the receptor subunit driving the 
association is unclear.  Recent work in mice has highlighted a possible role for variants in the 
Gabr β1 subunit (Gabrβ1) in alcohol dependence risk, although this gene does not contain 
any common non-synonymous variants in man.  However, the GABAA receptor is a hetero-
pentamer so multiple potential variants within the gene complex could generate the alcohol 
dependence phenotype.  
Methods: The association between GABRβ1 variants and alcohol dependence risk was 
explored in a British and Irish population of alcohol dependent cases (n=450) and ancestrally-
matched, controls screened to exclude current or historical alcohol misuse (n=555).  Twelve 
common single nucleotide polymorphisms (SNPs), and a rare non-synonymous variant, 
rs41311286, were directly genotyped; imputation was then performed across the whole 
gene.  
Results: No allelic association was observed between alcohol dependence risk and any of the 
directly genotyped or imputed SNPs.  However, post-hoc testing for genotypic association 
identified five common intronic SNPs which showed modest evidence for association after 
correction for multiple testing; two, rs76112682 and rs141719901, were in complete linkage 
disequilibrium (Pcorrected=0.02, OR [95% CI] = 5.9 [1.7-2.06]).  
Conclusion: These findings provide limited support for an association between GABRβ1 and 
the risk of developing alcohol dependence; further testing in expanded cohorts may be 
warranted.   
 
Keywords: Alcohol dependence, British, GABA receptor, GABRΒ1, Genetic association, 
imputation analysis, Irish, linkage disequilibrium 
3 
 
 
 
Introduction 
Alcohol dependence is a complex disorder which contributes substantially to the global burden 
of disability and death (World Health Organisation, 2014).  Genetic factors undoubtedly play a 
role in the development of this condition but the identification of the exact risk variants has 
proven difficult (Stickel et al., 2016).   
Alcohol interacts with several neurotransmitter membrane receptors and ion channels (Enoch, 
2008); it specifically alters the ratio of the inhibitory neurotransmitter γ-aminobutyric acid 
(GABA) to the excitatory neurotransmitter glutamate, both of which bind to GABA receptors in 
the brain.  Thus, genetic variations in the genes encoding key GABA receptors may influence 
the effects of alcohol on the brain and hence the risk for developing alcohol dependence 
(Enoch, 2003; Enoch, 2008).  The GABAA receptor is a hetero-pentamer consisting of five 
subunits; thus several different genes encode the subunit proteins which make up the complex 
(Kumar et al., 2009; Kelm et al., 2010; Stephens et al., 2016).  
Previous studies have identified an association between GABA receptor genes and alcohol 
dependence risk, but with attribution to different receptor subunits.  Risk association with 
microsatellite markers corresponding to introns in the GABA β1 subunit (GABRβ1) have been 
reported and replicated in several populations (Long et al., 1998; Parsian and Zhang 1999; Song 
et al., 2003; Zhang et al., 2005; Reck et al., 2005) but not necessarily all (Drgon et al., 2006; 
Couvalt et al., 2008; Mathews et al., 2007; Lydall et al., 2011) and no significant associations 
have been identified with genes in the GABA receptor cluster in genome–wide association 
studies (GWAS) of alcohol dependence risk (Stickel et al, 2016). 
Interest in the role of GABRβ1 in mediating alcohol dependence risk in man was revived 
recently following identification of two functional mutations in murine Gabrβ1 which are 
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associated with the development of a strong motivation to consume alcohol in mouse strains 
which are normally highly alcohol averse (Anstee et al., 2013).  These mutations correspond to 
L285R and P228H, neither of which has a common human homologue: L285R corresponds to 
human residue 310 and only one person with variation in this residue has been identified 
amongst the 60,706 individuals in the Exome Aggregation Consortium (ExAC) data (Lek et al., 
2016); P228H corresponds to human residue 253 -- no variants affecting this residue have been 
identified in the ExAC data (Lek et al., 2016). 
There are, in fact, no common (>1% minor allele frequency) non-synonymous variants in 
GABRβ1.  In European populations, rs41311286 (His421Gln), the variant most frequently 
observed, has a minor allele frequency of only 0.4% (Lek et al., 2016).  Nevertheless, GABRβ1 is 
comprised of over 99.7% intronic DNA, which may contain genetic variations which could for 
example, influence mRNA stability and transcriptional regulation and hence have functional 
effects (Shabalina et al., 2013).   Thus, the primary aim of this study was to investigate the 
association between variants in GABRβ1 and alcohol dependence risk, by conducting a two-
stage case-control study comprising of a primary allelic analysis of selected tagging SNPs 
followed by an imputation analysis extending the full length of the gene. 
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Methods 
Study populations 
Genomic DNA was available from 450 cases (mean [range] age: 52.0[20-81] yr: 47% men) and 
555 controls (mean age: 38.2[18-87] yr: 54% men).  The cases comprised of individuals 
diagnosed as alcohol dependent using the Diagnostic and Statistical Manual of Mental 
Disorders, 4th Edition (DSM-IV; American Psychiatric Association, 1994) criteria.  All were of 
English, Scottish, Welsh or Irish descent with a maximum of one grandparent of white 
European origin.  The controls comprised ancestrally-matched individuals none of whom had a 
past or current history of alcohol misuse. None of the included individuals was related.   
SNP selection and genotyping 
Thirteen single nucleotide polymorphisms (SNPs) were genotyped across GABRβ1 using the 
KBiosciences Competitive Allele Specific PCR (KASPar) genotyping platform (LGC Genomics, 
Hoddesdon, UK).  The selection included: (i) seven tagging SNPs around an intronic tetra-
nucleotide microsatellite marker, which had previously shown evidence for variation in 
humans (Dean et al., 1991); (ii) five additional tagging SNPs which, according to the HapMap 
project data, were predicted to provide additional mapping information across the gene, and 
(iii) rs413211286, the only non-synonymous SNP identified in the 1000 genomes European 
population (Abecasis et al., 2012) (Supplementary Fig. 1).  Amplification and detection was 
undertaken using a LightCycler® 480 Real-Time PCR machine (Roche Molecular Diagnostics, 
Burgess Hill, UK).   
Genotype calling was performed automatically by built-in Roche software with some manual 
editing.  Approximately 12% of samples, randomly selected a priori, were genotyped in 
duplicate.  Samples with conflicting calls (<0.05% of total) were excluded from further analyses. 
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Imputation 
Imputation was performed using IMPUTE2 v2.3.2 using phase 3 integrated reference 
haplotypes from the 1000 genomes sequencing project (Haplotype release date October 2014) 
(www.1000genomes.org/) as a reference panel (Abecasis et al., 2012).  The imputation was 
performed over the (hg19) region chr4:46,990,000-47,500,000 using recommended settings 
(Marchini et al., 2007). 
Statistical analyses 
Tests for primary allelic associations, missingness, deviation from Hardy-Weinberg equilibrium 
(HWE) and linkage disequilibrium were performed using PLINK version 1.9 (Purcell et al., 2007; 
Chang et al., 2015).  The selection of SNPs for testing for association with alcohol dependence 
risk was restricted to directly genotyped SNPs with a minor allele frequency (MAF) >0.05 and 
imputed SNPs with a MAF >0.05 and an info score > 0.9.  Further post hoc tests of association 
were performed using the model method and results reported on additive, recessive and 
dominant models of association.  The model with the lowest P-value was used for each SNP; 
only those SNPs with a P value less than 0.05 were explored further (González et al., 2008).  
The P value for each SNP was individually corrected for multiple testing using SNPSpD method 
(Nyholt, 2004).  Sex differences in identified genotypic associations were explored using logistic 
regression with sex as a covariate. 
SNP annotation  
Intergenic SNPs were annotated for known and predicted regulatory elements using 
RegulomeDB v.1.1 (www.regulomedb.org/) and HaploReg v.4.1 
(archive.broadinstitute.org/mammals/haploreg/haploreg.php).  The GTEx Consortium 
database (www.gtexportal.org/home/) and the braineac database (www.braineac.org/) were 
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interrogated to identify the effects of SNPs associated with the risk for developing alcohol 
dependence on brain GABRβ1 transcript expression.  A regional plot of the association data 
was generated using LocusZoom (Prium 2010).  
Ethics 
United Kingdom National Health Service Multicentre Research Ethics Committee approval was 
granted for this study (MREC/03/11/090).  Written informed consent was obtained from all 
subjects prior to inclusion. 
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Results 
Genotyping accuracy 
The call rates for all 13 directly genotyped SNPs were greater than 95% and they were all in 
Hardy Weinberg Equilibrium to P > 0.01.  
Genetic association with the directly genotyped single nucleotide polymorphisms 
There was no evidence of allelic association between the directly genotyped SNPs and alcohol 
dependence risk (Table 1).  Post hoc testing showed evidence of genotypic association with 
alcohol dependence risk for three SNPs, two of which, rs2044081 (Pcorrected=0.034) and 
rs17539445 (Pcorrected=0.024) retained significance after correction for multiple testing 
(Supplementary Table 1, Supplemental digital content 2, http://links.lww.com/PG/A186).).  
Imputation 
Imputation returned data for 14,608 SNPs of which 12,627 were within the Ensembl accepted 
region for GABRβ1 viz. chr4:46,993,723-47,426,444.  One hundred and thirty four SNPs met 
quality control criteria and were tested for association. 
Genetic association with the imputed single nucleotide polymorphisms 
There was no evidence for allelic association with alcohol dependence risk for any of the 
imputed SNPs (data not shown).  Post hoc tests of genotypic association with a recessive model 
showed uncorrected evidence for association with alcohol dependence risk for 36 imputed 
SNPs, all located within intron 4 of the GABRβ1 transcript (Supplementary Fig. 2;).  Five of 
these SNPs retained significance after correction for multiple testing including two, rs2044081 
and rs17539445 previously identified by direct genotyping (Table 2); two of the other three 
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SNPs, rs76112682 and rs141719901, were in complete linkage disequilibrium (Pcorrected=0.02, 
odds ratio [95% CI] = 5.9[1.7-2.06]).   
The associations with alcohol dependence risk identified by direct genotyping and by 
imputation were not significantly affected when sex was included as a covariate in the analyses 
(data not shown). 
Single nucleotide polymorphism annotation 
There was weak evidence from RegulomeDB v.1.1 that one SNP with evidence for association 
with alcohol dependence risk, rs17539445, lies in a binding site for the transcription factor Sex 
Determining Region Y Box 1 (SOX1), while a further associated SNP, rs141719901, lies in a 
binding site for Eomesodermin (EOMES) (Badis et al., 2009).   
There was no evidence from HaploReg v.4.1 that rs17539445 and rs141719901 were located in 
brain enhancer histone marked regions.  However, both SNPs were in strong linkage 
disequilibrium (LD; r2 >= 0.8) with six SNPs (rs7660967, rs73247673, rs2044081, rs5858060, 
rs6447543 and rs4635792) that were located in these regions. 
There was no evidence from the GTEx Consortium database that either rs17539445 or 
rs141719901 act as a brain expression quantitative trait locus (eQTL) for the GABRβ1 transcript. 
Likewise there was no evidence from the braineac database that rs17539445 is a brain eQTL 
for the GABRβ1 transcript; no data were available on rs141719901 from this source. 
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Discussion 
In the present study, direct genotyping and subsequent imputation of SNPs across GABRβ1 
provided a number of potentially interesting associations with alcohol dependence risk, 
including five intronic SNPs which retained significance after correcting for multiple testing.  
Two of these SNPs mapped genotypic information across regions of micro-satellite markers 
previously associated with alcohol dependence risk (Long et al., 1998, Parsian and Zhang 1999, 
Song et al., 2003, Zhang et al., 2005). 
The GABRβ1 gene has comparatively large introns (>100 kb) and relatively small exons (~0.1 
kb).  The only non-synonymous variant available for testing showed no genotypic or allelic 
evidence for association with alcohol dependence risk.  However, this SNP is rare in European 
populations meaning that this study was likely underpowered to detect genetic association 
(Skol et al., 2006).  Thus, the significance of any association with this SNP and alcohol 
dependence risk would need to be explored in much larger cohorts.  
Post hoc testing identified associations between common intronic variants in GABRβ1 and 
alcohol dependence risk.  These associations may be primary, or reflect the high level of 
linkage disequilibrium across and beyond GABRβ1, or association signals from variants in 
nearby loci such as, GABRα4, which is directly downstream from GABRβ1, or GABRα2 which is 
approximately 570kb further downstream from GABRβ1.   
It is also possible that intronic and/or synonymous variants could impact on levels of protein 
expression (Barrett et al., 2012) and hence might be directly associated with alcohol 
dependence risk.  Alcohol, taken acutely, stimulates the production of GABA and enhances 
GABAA receptor potentiation (Kumar et al., 2009).  Chronic exposure to alcohol might result in 
neuronal adaptation with attenuation of the GABA receptors to restore the homeostasis of 
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excitatory and inhibitory neurotransmission (Kumar et al., 2009).  If, under these circumstances, 
intronic variants in GABRβ1 alter the expression level or the half-life of the mRNAs this might 
further attenuate GABRβ1 expression and might result in an association with disease 
phenotype.  Furthermore, attenuation of a single subunit would impact on the subunit ratio 
and in turn the pentameric isoform ratios; this could also cause an overall alteration in ion 
channel gating, thus replicating the effect of the reported mutations in Gabrβ1 (Anstee et al., 
2013).  However, the fact that several of the variants are in strong linkage disequilibrium 
means that the effect of any one SNP is likely to be very small and it would be difficult to 
identify influential haplotype combinations.  This might explain the contradictory evidence for 
association with alcohol dependence risk seen across previous studies, and may explain why 
the recessive model of association provided the most significant associations. 
Two of the SNPs which showed modest genotypic evidence for association with alcohol 
dependence risk, rs17539445 and rs141719901 were predicted to lie in SOX1 and EOMES 
transcription factor binding sites.  In addition, both SNPs are in strong LD with six SNPs in brain 
tissue enhancer histone marked regions.  Interference with transcription factor binding and/or 
histone binding could impact on expression levels of GABRβ1.  However, there was no 
evidence, from available databases, that either SNP acts as a brain eQTL.  None of the other 
SNPs that showed genotypic association with alcohol dependence risk were predicted to 
correspond to an obvious regulatory element.  
In conclusion, no allelic association was detected in this study between the tested SNPs and 
the risk for developing alcohol dependence in a British and Irish population.  However, modest 
genotypic associations were found with several intronic GABRβ1 SNPs which may directly 
influence alcohol dependence risk or may be in linkage disequilibrium with causal risk variants 
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in nearby genes, including other GABA receptor subunits.  Future studies should attempt to 
identify any linked functional variants and to better understand the effects of these intronic 
variants on the levels of protein expression and GABRβ1 composition.   
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Legends to Figures 
 
Supplementary Figure 1. The location of the directly genotyped and imputed SNPs in GABRΒ1 
The 13 directly genotyped intronic SNPs in GABRβ1 are marked in green.  The SNPs 
significantly associated with alcohol dependence risk are highlighted in yellow.  The 
position of the region homologous to the sequence surrounding the Gabrβ1 
mutations reported by Anstee et al. (2013) are included for reference and are 
marked in red.  The five SNPs in GABRΒ1 with moderate genotypic association in the 
post hoc analysis are shown in blue. 
 
Abbreviations: SNP: single nucleotide polymorphism 
Exons have been increased in size to aid visualisation  
 
Supplementary Figure 2.  Fine mapping of the 36 imputed SNPs associated with alcohol 
dependence, by position on Chromosome 4.   
 The colour of the markers represents the degree of inter-SNP linkage with red 
representing the highest degree.  rs76112682, which is highlighted in purple, is the 
most significantly associated SNP.  The recombination map is plotted as a blue line 
graph 
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Table 1: Genotype counts and tests of allelic associations between the directly genotyped SNPs in GABRβ1 and alcohol dependence risk. 
SNP Position Group n 
Minor 
Allele 
Genotype Counts MAF Chi-square OR (95% CI) 
Significance 
P 
 
P 
corrected 
rs11735112 47031755 
      GG GT TT          
Cases 435 
G 
109 207 119 0.49 
0.63 1.08 (0.90-1.29) 0.43 1.00 
Controls 543 119 273 151 0.47 
rs6447540 47208869 
      TT TC CC          
Cases 440 
T 
4 51 385 0.07 
1.45 1.26 (0.87-1.82) 0.23 1.00 
Controls 554 1 58 495 0.05 
rs4695199 47210752 
      CC CG GG          
Cases 449 
C 
4 67 378 0.08 
2.47 1.31 (0.94-1.83) 0.12 1.00 
Controls 553 1 70 482 0.07 
rs2044081 47216323 
      TT TC CC          
Cases 448 
T 
16 111 321 0.16 
2.15 1.20 (0.94-1.54) 0.14 1.00 
Controls 554 5 141 408 0.14 
rs1372497 47220321 
      CC CT TT          
Cases 444 
C 
68 181 195 0.36 
0.80 1.09 (0.90-1.31) 0.37 1.00 
Controls 552 63 247 242 0.34 
rs17539445 47229399 
      GG GT TT          
Cases 444 
G 
15 115 314 0.16 
2.44 1.22 (0.95-1.56) 0.12 1.00 
Controls 550 4 144 402 0.14 
rs7672100 47263573 
      GG GA AA          
Cases 432 
G 
34 169 229 0.27 
0.02 1.02 (0.83-1.24) 0.88 1.00 
Controls 549 43 212 294 0.27 
rs12651232 47272719 
      TT TA AA          
Cases 437 
T 
8 91 338 0.12 
1.59 0.84 (0.65-1.10) 0.21 1.00 
Controls 550 10 136 404 0.14 
       GG GT TT          
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Abbreviations: SNP: Single Nucleotide Polymorphism; MAF: Minor Allele Frequency; OR: Odds Ratio; CI: Confidence Interval;  
 
rs4586906 47276286 Cases 445 
G 
77 193 175 0.39 
0.25 1.05 (0.87-1.26) 0.62 1.00 
Controls 554 81 258 215 0.38 
rs13127214 47278539 
      CC CG GG          
Cases 448 
C 
6 84 358 0.11 
0.55 1.12 (0.83-1.49) 0.46 1.00 
Controls 551 1 105 445 0.10 
rs4695209 47283017 
      GG GC CC          
Cases 441 
G 
0 57 384 0.06 
0.01 1.02 (0.71-1.47) 0.91 1.00 
Controls 552 3 64 485 0.06 
rs2078610 47287037 
      GG GT TT          
Cases 441 
G 
63 229 149 0.40 
0.25 1.05 (0.87-1.26) 0.62 1.00 
Controls 548 96 237 215 0.39 
rs41311286 47425856 
   GG GC CC      
Cases 437 
G 
0 3 434 0.003 
0.15 0.75 (0.18-3.17) 0.70 1.00 
Controls 550 0 5 545 0.005 
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Table 2:  Estimated genotype counts and tests of genotypic association for imputed SNPs in GABRβ1 with alcohol dependence risk 
 
SNP Group n 
Minor 
Allele 
Genotype Counts MAF 
OR 
(95% CI) 
Significance 
P P corrected 
rs2044081* 
 
      TT TC CC         
Cases 448 
T 
16 111 321 0.16 4.1 
(1.5-11.2) 
3.36x10-3 3.89x10-2 
Controls 554 5 141 408 0.14 
rs17539445* 
 
      GG GT TT         
Cases 444 
G 
15 115 314 0.16 4.8 
(1.6-14.5) 
2.41x10-3 2.78x10-2 
Controls 550 4 144 402 0.14 
rs76112682 
 
      TT TC CC         
Cases 441 
T 
14 103 324 0.15 5.9 
(1.7-20.6) 
1.74x10-3 2.01x10-2 
Controls 541 3 127 411 0.12 
rs141719901
 
 
      AA AAG AGAG         
Cases 441 
A 
14 103 314 0.15 5.9 
(1.7-20.6) 
1.74x10-3 2.01x10-2 
Controls 541 3 127 411 0.12 
rs3114087 
 
      AA AG GG         
Cases 427 
A 
13 90 324 0.14 5.5 
(1.5-19.3) 
3.11x10-3 3.60x10-2 
Controls 526 3 114 409 0.11 
 
Abbreviations: SNP: Single Nucleotide Polymorphism; MAF: Minor Allele Frequency; OR: Odds Ratio; CI: Confidence Interval 
*SNPs also directly genotyped 
SNPs in complete linkage disequilibrium 
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Supplementary Table 1: Genotypic association between the directly genotyped SNPs in GABRβ1 and alcohol dependence risk 
SNP 
(Model) 
Group n 
Minor 
Allele 
Genotype Counts MAF OR (95% CI) 
Significance 
P 
 
P 
corrected 
       GG GT TT         
rs11735112 
(Recessive) 
Cases 435 
G 
109 207 119 0.49 
0.84 (0.62-1.13) 0.25 1.00 
Controls 543 119 273 151 0.47 
       TT TC CC         
rs6447540 
(Recessive) 
Cases 440 
T 
4 51 385 0.07 
0.20 (0.02-1.77) 0.10 1.00 
Controls 554 1 58 495 0.05 
       CC CG GG         
rs4695199 
(Recessive) 
Cases 449 
C 
4 67 378 0.08 
0.20 (0.02-1.81) 0.11 1.00 
Controls 553 1 70 482 0.07 
       TT TC CC         
rs2044081 
(Recessive) 
Cases 448 
T 
16 111 321 0.16 
0.24 (0.09-0.68) 3.36X10-3 3.36x10-2 
Controls 554 5 141 408 0.14 
       CC CT TT         
rs1372497 
(Recessive) 
Cases 444 
C 
68 181 195 0.36 
0.71 (0.49-1.03) 0.07 0.70 
Controls 552 63 247 242 0.34 
       GG GT TT         
rs17539445 
(Recessive) 
Cases 444 
G 
15 115 314 0.16 
0.21 (0.07-0.64) 2.41X10-3 2.41x10-2 
Controls 550 4 144 402 0.14 
       GG GA AA         
rs7672100 
(Dominant) 
Cases 432 
G 
34 169 229 0.27 
0.98 (0.76-1.16) 0.87 1.00 
Controls 549 43 212 294 0.27 
       TT TA AA         
rs12651232 
(Dominant) 
Cases 437 
T 
8 91 338 0.12 
1.23 (0.92-1.65) 0.15 1.00 
Controls 550 10 136 404 0.14 
      GG GT TT         
23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: SNP: Single Nucleotide Polymorphism; MAF: Minor Allele Frequency; OR: Odds Ratio; CI: Confidence Interval;  
Significantly associated SNPs are annotated in bold type 
 
 
rs4586906 
(Recessive) 
Cases 445 
G 
77 193 175 0.39 
0.82 (0.58-1.15) 0.25 1.00 
Controls 554 81 258 215 0.38 
       CC CG GG         
rs13127214 
(Recessive) 
Cases 448 
C 
6 84 358 0.11 
0.13 (0.02-1.12) 0.03 0.29 
Controls 551 1 105 445 0.10 
       GG GC CC         
rs4695209* 
(Recessive) 
Cases 441 
G 
0 57 384 0.06 
0.98 (0.98-1.02) 0.92 1.00 
Controls 552 3 64 485 0.06 
       GG GT TT         
rs2078610 
(Dominant)) 
Cases 441 
G 
63 229 149 0.40 
0.79 (0.61-1.03) 0.07 0.77 
Controls 548 96 237 215 0.39 
    GG GC CC     
rs41311286* 
(Recessive) 
Cases 437 
G 
0 3 434 0.003 
1.33 (0.32-5.56) 0.97 1.00 
Controls 550 0 5 545 0.005 
